Distributed exclusively to licensed dental professionals by Discus Dental, Inc, Culver City, California . Aphthasol is the first FDA-approved and only prescription drug specifically indicated for the treatment of aphthous ulcers in healthy adults. Studies show that up to 25 percent of dental patients suffer from Recurrent Aphthous Ulcers (RAU), but, until now, treatment options have only been marginally effective or simply masked the symptoms. Finally, Aphthasol® is clinically proven to accelerate healing and reduce pain.
Aphthasol, Amlexanox Oral Paste (5%), is a tasteless and odorless mucoadhesive paste that is known to be a potent inhibitor of mast cells and allergic response. Mast cells are found in greater quantities in Recurrent Aphthous Ulcer lesions when compared with healthy mucosa. Aphthasol is believed to work by both providing a protective barrier over the ulcer(s) and inhibiting mast cells. FDA clinical trials have shown that Aphthasol accelerates healing of ulcers and reduces associated pain with minimal side affects. Aphthasol is proven to provide 72% faster healing time and 90% faster pain resolution when compared to no treatment. The study further shows 21% of patients treated with Aphthasol experienced complete ulcer healing by day 3, while 44% of patients experienced pain relief by day 3. Aphthasol is available to licensed dental professionals in the United States exclusively through Discus Dental, Inc.
Help your patients treat this common problem by contacting Discus Dental at 1-800-422-9448 or visiting www.discusdental.com today.